Beneath the Fatty Liver: Screening for Bone, Muscle and Vitamin D Deficits and Risk-Tailored Rehabilitation in Young and Middle-Aged Patients with MASLD
Year: 2026
Type: article
Study design: Clinical Trial
Abstract: Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) in younger and middle-aged adults may coexist with abnormalities in bone mineral density, muscle mass and vitamin D status that are not routinely assessed. Objective: To examine these abnormalities and evaluate risk-tailored rehabilitation alongside standard treatment. Methods: In this prospective, controlled, parallel-group study, 111 participants were assessed: 91 patients aged 18–59 years with MASLD and 20 healthy controls. Patients received standard treatment (group I; n = 47) or standard treatment with a risk-tailored rehabilitation programme (group II; n = 44), with assessments over 12 months. Dual-energy X-ray absorptiometry, serum 25(OH)D, metabolic indices and liver measurements were used. Results: Reduced bone mineral density and vitamin D deficiency were each identified in 53.8% of patients, and low muscle mass in 24.2%. Lower vitamin D status was associated with less favourable bone, metabolic and hepatic indices. At 12 months, body weight decreased by 3.1% in group I and 7.3% in group II, CAP by 7.9% and 18.6%, and HOMA-IR by 20.9% and 44.4%, respectively. Serum 25(OH)D increased from 19.4 to 22.1 ng/mL in group I and from 18.9 to 34.6 ng/mL in group II. L1–L4 bone mineral density changed by −1.3% and +1.5%, respectively, without statistically significant within-group changes. Conclusion: The findings support further evaluation of integrated musculoskeletal screening and risk-tailored rehabilitation in MASLD.
Institution: Tashkent State Medical University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7236823012
